Skip to content
Home/Companies/MedTech/Implandata Ophthalmic Products GmbH
IO

Implandata Ophthalmic Products GmbH

MedTech·Germany·Active·7yr hold

Implandata Ophthalmic Products GmbH is a MedTech company, headquartered in Germany.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Implandata Ophthalmic Products GmbH?

Implandata Ophthalmic Products GmbH is currently owned by NBank Capital through NBank Capital Beteiligungsfonds (2009 vintage), since 2019.

Hand-verified · updated 2026-07-03

NBank Capital
Investor
NBank Capital
NBank Capital Beteiligungsfonds · 2009 · Evergreen

Key facts

HQGermany
SectorMedTech
StatusActive

More from NBank Capital Beteiligungsfonds

Other portfolio companies in the same fund.

BIOWEG GmbH
Active
ClimateTechGermany· 2025
Phaeosynt GmbH
Active
BiotechGermany· 2025
Skyseed GmbH
Active
ClimateTechGermany· 2025
Allogenetics GmbH
Active
BiotechGermany· 2024
Sascotec Horsepower GmbH
Active
IndustrialsGermany· 2024
NEXSD Automotive Innovations GmbH
Active
MobilityGermany· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings